These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2795463

  • 1. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V, Dromer F, Barge J, Yeni P, Seta N, Molas G, Carbon C.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [Abstract] [Full Text] [Related]

  • 2. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture.
    Joly V, Saint-Julien L, Carbon C, Yeni P.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):17-22. PubMed ID: 2213553
    [Abstract] [Full Text] [Related]

  • 3. Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
    Krause HJ, Juliano RL.
    Mol Pharmacol; 1988 Sep; 34(3):286-97. PubMed ID: 3419424
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
    Juliano RL, Grant CW, Barber KR, Kalp MA.
    Mol Pharmacol; 1987 Jan; 31(1):1-11. PubMed ID: 3807887
    [Abstract] [Full Text] [Related]

  • 5. Development of liposomal amphotericin B formulation.
    Gulati M, Bajad S, Singh S, Ferdous AJ, Singh M.
    J Microencapsul; 1998 Jan; 15(2):137-51. PubMed ID: 9532520
    [Abstract] [Full Text] [Related]

  • 6. The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity.
    Gerkens JF, Branch RA.
    J Pharmacol Exp Ther; 1980 Aug; 214(2):306-11. PubMed ID: 7391978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK, Naik SR.
    J Pharm Pharm Sci; 2003 Aug; 6(2):231-7. PubMed ID: 12935435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of aminophylline on amphotericin B nephrotoxicity in the dog.
    Gerkens JF, Heidemann HT, Jackson EK, Branch RA.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):609-13. PubMed ID: 6298404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Cybulska B, Kupczyk K, Szlinder-Richert J, Borowski E.
    Acta Biochim Pol; 2002 Mar; 49(1):67-75. PubMed ID: 12136958
    [Abstract] [Full Text] [Related]

  • 19. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
    Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ.
    Bone Marrow Transplant; 2004 Mar; 33(5):543-8. PubMed ID: 14730342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.